212 related articles for article (PubMed ID: 29535718)
1. Group A
Clark M; Kim J; Etesami N; Shimamoto J; Whalen RV; Martin G; Okumura CYM
Front Immunol; 2018; 9():327. PubMed ID: 29535718
[TBL] [Abstract][Full Text] [Related]
2. Mast cell cathelicidin antimicrobial peptide prevents invasive group A Streptococcus infection of the skin.
Di Nardo A; Yamasaki K; Dorschner RA; Lai Y; Gallo RL
J Immunol; 2008 Jun; 180(11):7565-73. PubMed ID: 18490758
[TBL] [Abstract][Full Text] [Related]
3. Skin mast cells protect mice against vaccinia virus by triggering mast cell receptor S1PR2 and releasing antimicrobial peptides.
Wang Z; Lai Y; Bernard JJ; Macleod DT; Cogen AL; Moss B; Di Nardo A
J Immunol; 2012 Jan; 188(1):345-57. PubMed ID: 22140255
[TBL] [Abstract][Full Text] [Related]
4. Phagocytosis-independent antimicrobial activity of mast cells by means of extracellular trap formation.
von Köckritz-Blickwede M; Goldmann O; Thulin P; Heinemann K; Norrby-Teglund A; Rohde M; Medina E
Blood; 2008 Mar; 111(6):3070-80. PubMed ID: 18182576
[TBL] [Abstract][Full Text] [Related]
5. Dermal mast cells reduce progressive tissue necrosis caused by subcutaneous infection with Streptococcus pyogenes in mice.
Matsui H; Sekiya Y; Takahashi T; Nakamura M; Imanishi K; Yoshida H; Murayama SY; Takahashi T; Tsuchimoto K; Uchiyama T; Ubukata K
J Med Microbiol; 2011 Jan; 60(Pt 1):128-134. PubMed ID: 20884771
[TBL] [Abstract][Full Text] [Related]
6. Group A Streptococcal M1 Protein Sequesters Cathelicidin to Evade Innate Immune Killing.
LaRock CN; Döhrmann S; Todd J; Corriden R; Olson J; Johannssen T; Lepenies B; Gallo RL; Ghosh P; Nizet V
Cell Host Microbe; 2015 Oct; 18(4):471-7. PubMed ID: 26468750
[TBL] [Abstract][Full Text] [Related]
7. Human-derived cathelicidin LL-37 directly activates mast cells to proinflammatory mediator synthesis and migratory response.
Bąbolewska E; Brzezińska-Błaszczyk E
Cell Immunol; 2015 Feb; 293(2):67-73. PubMed ID: 25577339
[TBL] [Abstract][Full Text] [Related]
8. Cathelicidin LL-37 in severe Streptococcus pyogenes soft tissue infections in humans.
Johansson L; Thulin P; Sendi P; Hertzén E; Linder A; Akesson P; Low DE; Agerberth B; Norrby-Teglund A
Infect Immun; 2008 Aug; 76(8):3399-404. PubMed ID: 18490458
[TBL] [Abstract][Full Text] [Related]
9. The host defense peptide LL-37 triggers release of nucleic acids from human mast cells.
Dahl S; Anders E; Gidlöf O; Svensson D; Nilsson BO
Peptides; 2018 Nov; 109():39-45. PubMed ID: 30308233
[TBL] [Abstract][Full Text] [Related]
10. Host Cathelicidin Exacerbates Group B
Patras KA; Coady A; Babu P; Shing SR; Ha AD; Rooholfada E; Brandt SL; Geriak M; Gallo RL; Nizet V
mSphere; 2020 Apr; 5(2):. PubMed ID: 32321824
[TBL] [Abstract][Full Text] [Related]
11. The cysteine protease ApdS from
Xie F; Zan Y; Zhang Y; Zheng N; Yan Q; Zhang W; Zhang H; Jin M; Chen F; Zhang X; Liu S
J Biol Chem; 2019 Nov; 294(47):17962-17977. PubMed ID: 31619521
[No Abstract] [Full Text] [Related]
12. Mast Cell Cytonemes as a Defense Mechanism against Coxiella burnetii.
Mezouar S; Vitte J; Gorvel L; Ben Amara A; Desnues B; Mege JL
mBio; 2019 Apr; 10(2):. PubMed ID: 30992359
[TBL] [Abstract][Full Text] [Related]
13. Innate antimicrobial peptide protects the skin from invasive bacterial infection.
Nizet V; Ohtake T; Lauth X; Trowbridge J; Rudisill J; Dorschner RA; Pestonjamasp V; Piraino J; Huttner K; Gallo RL
Nature; 2001 Nov; 414(6862):454-7. PubMed ID: 11719807
[TBL] [Abstract][Full Text] [Related]
14. Keratinocyte production of cathelicidin provides direct activity against bacterial skin pathogens.
Braff MH; Zaiou M; Fierer J; Nizet V; Gallo RL
Infect Immun; 2005 Oct; 73(10):6771-81. PubMed ID: 16177355
[TBL] [Abstract][Full Text] [Related]
15. Streptococcal H2O2 inhibits IgE-triggered degranulation of RBL-2H3 mast cell/basophil cell line by inducing cell death.
Okahashi N; Nakata M; Hirose Y; Morisaki H; Kataoka H; Kuwata H; Kawabata S
PLoS One; 2020; 15(4):e0231101. PubMed ID: 32302339
[TBL] [Abstract][Full Text] [Related]
16.
Campillo-Navarro M; Leyva-Paredes K; Donis-Maturano L; Rodríguez-López GM; Soria-Castro R; García-Pérez BE; Puebla-Osorio N; Ullrich SE; Luna-Herrera J; Flores-Romo L; Sumano-López H; Pérez-Tapia SM; Estrada-Parra S; Estrada-García I; Chacón-Salinas R
Front Immunol; 2018; 9():1161. PubMed ID: 29892297
[TBL] [Abstract][Full Text] [Related]
17. Listeria monocytogenes induces mast cell extracellular traps.
Campillo-Navarro M; Leyva-Paredes K; Donis-Maturano L; González-Jiménez M; Paredes-Vivas Y; Cerbulo-Vázquez A; Serafín-López J; García-Pérez B; Ullrich SE; Flores-Romo L; Pérez-Tapia SM; Estrada-Parra S; Estrada-García I; Chacón-Salinas R
Immunobiology; 2017 Feb; 222(2):432-439. PubMed ID: 27520114
[TBL] [Abstract][Full Text] [Related]
18. Cutting edge: mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide.
Di Nardo A; Vitiello A; Gallo RL
J Immunol; 2003 Mar; 170(5):2274-8. PubMed ID: 12594247
[TBL] [Abstract][Full Text] [Related]
19. Significance of Mast Cell Formed Extracellular Traps in Microbial Defense.
Elieh Ali Komi D; Kuebler WM
Clin Rev Allergy Immunol; 2022 Feb; 62(1):160-179. PubMed ID: 34024033
[TBL] [Abstract][Full Text] [Related]
20. Urticaria Neonatorum: accumulation of tryptase-expressing mast cells in the skin lesions of newborns with Erythema Toxicum.
Nelson A; Ulfgren AK; Edner J; Ståbi B; Brismar H; Hultenby K; Marchini G
Pediatr Allergy Immunol; 2007 Dec; 18(8):652-8. PubMed ID: 18078419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
